In 2012, we reported that 5 out of 11 subjects in a clinical trial (NCT00372320) administering AdhAQP1 to radiation-damaged parotid glands showed increased saliva flow rates and decreased symptoms over the initial 42 days. AdhAQP1 is a first-generation, E1-deleted, replication-defective, serotype 5 adenoviral vector encoding human aquaporin-1 (hAQP1). This vector uses the human cytomegalovirus enhancer/promoter (hCMVp). As subject peak responses were at times much longer (7-42 days) than expected, we hypothesized that the hCMVp may not be methylated in human salivary gland cells to the extent previously observed in rodent salivary gland cells. This hypothesis was supported in human salivary gland primary cultures and human salivary gland cell lines after transduction with AdhAQP1. Importantly, hAQP1 maintained its function in those cells. Conversely, when we transduced mouse and rat cell lines in vitro and submandibular glands in vivo with AdhAQP1, the hCMVp was gradually methylated over time and associated with decreased hAQP1 expression and function in vitro and decreased hAQP1 expression in vivo. These data suggest that the hCMVp in AdhAQP1was probably not methylated in transduced human salivary gland cells of responding subjects, resulting in an unexpectedly longer functional expression of hAQP1.
INTRODUCTION
To test a novel treatment for radiation-induced salivary hypofunction, we carried out a phase I clinical trial in which a locally delivered gene therapy vector was used to re-engineer the remaining parotid gland epithelial cells to regain the ability to secrete fluid. 1 The primary endpoint of this clinical trial was safety; however, we observed a long-lasting increase in salivary secretion in 5 subjects (out of 11 total subjects) compared with their own baseline, following a quite different time course than seen in preclinical animal studies, with times of peak secretion ranging from 7-42 days ( Figure 1 ). 1 Furthermore, after vector delivery to a single parotid gland, all of these responders reported an improvement in symptoms that were of life-altering quality. 1 Nonresponse was associated in three subjects with increased immune reactivity in an AdhAQP1 dose-dependent manner 1 and in one subject with a latent adenovirus serotype 5 (Ad5) infection in the targeted parotid gland. 2 In the remaining two subjects, one presented with a severely aberrant 99m TcO 4 scintiscan before AdhAQP1 treatment, probably indicating remarkable functional changes in surviving epithelial cells, 1 whereas the final nonresponder showed a peak increase in salivary flow rate at day 14, but experienced no relief of multiple symptoms of salivary hypofunction. 1 In that study, we used a first-generation, E1-deleted, replication-defective Ad5 AdhAQP1, to deliver the human aquaporin-1 (hAQP1) cDNA using the human cytomegalovirus (hCMV) promoter (hCMVp).
hCMV is a member of the herpes virus family and belongs to the Betaherpesvirinae subfamily. Over 50% of the US population is infected by hCMV. 3, 4 Importantly, many studies found that salivary glands are a preferential site for infections, serving as reservoirs for hCMV residence in both human and animals (for example, mouse, rat, little brown bat and guinea pig). [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Both acinar and ductal salivary epithelial cells can be infected by hCMV. 5, [10] [11] [12] After infection, hCMV can remain latent for the rest of the host's life, maintaining the viral genome without the production of infectious virions. [16] [17] [18] The hCMVp is a frequently used enhancer/promoter in many gene transfer vectors. It is also known that the hCMVp is methylated readily, leading to transcriptional silencing. [19] [20] [21] [22] [23] [24] [25] [26] After reviewing the literature about hCMVp methylation, we recognized that most relevant studies used animals or animal cells. [19] [20] [21] [22] [23] [24] [25] In addition, none of these key studies used salivary glands or salivary gland cells to examine hCMVp methylation. The unusually long time to peak salivary secretion observed among responders in our clinical trial, coupled with the lack of published information about the hCMVp in human salivary gland cells, led us to assess the methylation status of the hCMVp in human salivary cell lines and primary cell cultures. Concomitantly, we tested mouse and rat cells in vitro and in vivo to evaluate the methylation pattern of the hCMVp in the animal models used most commonly for pre-clinical gene therapy studies.
RESULTS

Methylation status of hCMVp in vitro/in vivo
The hCMVp used in AdhAQP1 was 773 bp long ( Figure 2a ). Initially, we performed two PCR assays (PCR 1 and PCR 2), which demonstrated that all cell lines, primary cultures, and mouse and rat submandibular glands employed herein were negative for the hCMVp before being transduced with AdhAQP1 ( Figure 2b ). We next designed a PCR strategy to amplify a 256-bp bisulfite amplicon from nt 487 to nt 743 (sequences in red in Figure 2a ). Furthermore, we analyzed the 153 bp from nt 549 to nt 702 from the bisulfite sequence data (shown in Table 1 ), a region in which there are 41 cytosines with 11 cytosines in a CpG motif.
The PCR assay results from human parotid gland primary cell cultures, human minor salivary gland primary cell cultures and the human salivary cell lines (HSG, submandibular; HSY, parotid) showed an absence of methylation 1 week post transduction with AdhAQP1 (Table 1 and Figure 3 ). For rodent studies, we employed C3H mice and Wistar rats for in-vivo experiments and three cell lines (A5 and SMIE, both rat submandibular, and NIH 3T3, mouse fibroblast) for in-vitro experiments. A total of 10 9 vector particles/ gland were delivered to either mouse or rat submandibular glands via retrograde ductal instillation. In-vivo data from rodent studies demonstrated that the posttransduction methylation of the hCMVp increased over time (Table 1 and Figure 3 ). Furthermore, on day 7 the cytosines in the hCMVp sequence analyzed were over 90% methylated in all three rodent cell lines (Table 1 and Figure 3 ). These data clearly demonstrate that the hCMVp is more susceptible to methylation in vector-targeted rodent cells compared with vector-targeted human salivary cells. The data also demonstrate that cytosines in both CpG and non-CpG motifs could be methylated, with essentially no difference observed in the frequency between the two sites. Other studies have also reported that cytosines in non-CpG sites can be methylated. 21, 27, 28 Association of hCMVp methylation with reduced hAQP1 function and protein expression Next, we investigated whether the methylation of the hCMVp affects hAQP1 function and protein expression. First, we compared rat A5 cells and human HSG cells after transduction with AdhAQP1 in vitro. The key physiological function of the AQP1 protein is to mediate facilitated, osmotically driven transmembrane water movement. As the transmembrane water movement will cause cell volume change, we evaluated functional hAQP1 expression by measuring cell volume change in vitro.
Cell volume increased after administration of a hypotonic solution and reached a maximum within 2-3 min, then gradually returned to normal (regulatory volume decrease, RVD) for A5 and HSG cells transduced with the Adcontrol vector (Figures 4a and b for A5 cells and Figures 4f and g for HSG cells). On day 2 post transduction with AdhAQP1, cell volume changed in both cell lines, that is, cell volume changes in A5 and HSG cells were faster for both the initial increase in volume and later the decrease (RVD) compared with that of Adcontrol groups (Figures 4a and f ). However, on day 7 post transduction, there was no difference in cell volume in response to a hypotonic solution between A5 cells transduced with AdhAQP1 or Adcontrol (Figure 4b ). Conversely, in HSG cells there was still a remarkable difference in cell volume changes between AdhAQP1-and Adcontrol-transduced cells on day 7 post transduction. The change was similar to the those observed on day 2, that is, faster cell volume change for both initial increase in volume and decrease (RVD) in the AdhAQP1transduced HSG cells ( Figure 4g ).
The peak time to reach maximum volume in both A5 and HSG cells transduced with AdhAQP1 was significantly shorter than that of cells transduced with Adcontrol on day 2. On day 7, however, the HSG cells reached the maximum volume about the same time as on day 2, whereas there was no difference between AdhAQP1and the Adcontrol-treated A5 cells on day 7 (Figures 4c and h) . Similarly, the percentages of RVD at 5 min in both A5 and HSG cells transduced with AdhAQP1 were significantly increased compared with cells transduced with Adcontrol on day 2 (Figures 4d and i). However, on day 7 there was no statistical difference in the RVD responses of Adcontrol-and AdhAQP1treated A5 cells, whereas similarly transduced HSG cells exhibited the same RVD responses as observed on day 2 (Figures 4d and i) . Importantly, the function of hAQP1 in both cells was consistent with protein expression as assessed by western blottings (Figures 4e and j) , that is, lower hAQP1 expression in rodent cells on day 7, consistent with the methylation assay results ( Figure 3 and Table 1 ). The methylation data shown in Table 1 indicate that hCMVp methylation in A5 cells was at a much higher level (490%) on day 7 than seen in HSG cells, where no methylation was detected on day 7.
In addition, we wanted to examine AdhAQP1-transduced submandibular glands of mice and rats to evaluate whether Figure 3 . Schematic depictions of representative data from the methylation (bisulfite conversion) assays. The figure only shows 61 bp from the 153 bp sequence analyzed in this study. The first row is the sequence from the native hCMVp used. Cytosines at CpG sites are highlighted in green, cytosines at non-CpG sites are highlighted in yellow, whereas cytosines converted to uracil and read as thymidine by bisulfite conversion assays are highlighted in magenta. Human parotid, human parotid gland primary culture 7 days post transduction with AdhAQP1; Human minor, human minor salivary gland primary culture 7 days post transduction with AdhAQP1; 2d, 2 days post transduction with AdhAQP1; 7d, 7 days post transduction with AdhAQP1; 14d, 14 days post transduction with AdhAQP1; SG, submandibular gland. hAQP1 expression in vivo was similarly associated with the methylation status measured ( Figure 3 and Table 1 To assess the actual transcription of the transgene, the hAQP1 mRNA levels were evaluated at each time point. As also shown in Figures 5a and e, the hAQP1 mRNA also decreased over time, although at a faster rate than that of the loss of vector particles. These data are consistent with the increased level of methylation in the hCMVp measured above ( Figure 3 and Table 1) . Similarly, hAQP1 protein expressed in these glands, as measured by western blots, was highest on day 2 and decreased steadily thereafter (Figures 5b and f) . Indeed, by day 14 hAQP1 protein expression returned to the background levels in mouse submandibular gland and slightly higher than background levels in rat submandibular gland (Figures 5b, c, f and g, respectively) . It is noteworthy that normally in mammalian salivary glands only red blood cells and endothelial cells are positive for AQP1 staining. 29 Results from immunofluorescence staining were consistent with that of cellular distribution (Figures 5d and h) , with positive signals in the control samples coming from the red blood cells and endothelial cells (yellow arrow in Figure 5I , mouse gland). The hAQP1-positive signals in acinar and ductal cells indicate those cells that were transduced by the AdhAQP1 and expressed hAQP1 (Figures 5d, h and i). Data from both mouse and rat showed that the hAQP1-positive signals in both types of salivary epithelial cells decreased over time (Figures 5d and h) . On day 14, it was difficult to find the hAQP1-positive signals in epithelial cells from mouse samples, whereas relatively few hAQP1-positive signals were detected in epithelial cells from rat samples (Figures 5d and h) . Overall, these results were consistent with the methylation data in Figure 3 and Table 1 .
Histological examinations revealed the presence of inflammatory cells in mouse submandibular glands on day 2 and 7, which subsided by day 14 (Figure 5d ). In rat submandibular glands, however, no clear histological alterations were observed at any of the posttransduction time points (Figure 5h ).
Evidence for hCMV exposure in the 11 subjects studied clinically Given the above results, we examined sera obtained from the 11 subjects studied in the AdhAQP1 clinical trial (Figure 1 ), 1 to determine whether an individual's possible previous exposure to hCMV might have influenced their ability to respond to the vector. We posited that subjects with a past exposure to hCMV would have a higher level of IgG class antibodies to hCMV in their sera and used an enzyme-linked immunosorbent assay for their detection. We tested serum samples, both obtained before AdhAQP1 administration and 42 days vector post transduction. The results showed that three responders and two nonresponders were positive for past hCMV exposure before AdhAQP1 administration, with comparable results found at the day 42 time point. These data suggest that a previous exposure to hCMV was unlikely to influence a subject's responsiveness to AdhAQP1 and, most probably, was without effect on the methylation status of the hCMVp.
DISCUSSION
Ad5 vectors have been frequently used in clinical trials, although first-generation Ad5 vectors are considered to be short lived. 30, 31 Based on observations from our recent clinical trial using AdhAQP1 in parotid glands, where the intended functional response (increased salivary secretion) in responders showed a quite different time course than seen in pre-clinical animal studies, with peak response times much longer than expected, 1 we hypothesized that one possible reason for this outcome could be the reduction or the absence of methylation in the hCMVp in transduced human parotid gland cells. Therefore, the present study was designed to determine the methylation status of the hCMVp in human salivary epithelial cells in vitro following AdhAQP1 transduction compared with that seen in mouse and rat cell lines in vitro and salivary glands in vivo. Although it would have been ideal to test our hypothesis directly and evaluate the extent of hCMVp methylation in parotid biopsy samples from subjects in the clinical trial, we were unable to do so, as the clinical protocol did not include approval for an open parotid gland biopsy from treated glands.
Ad5 vectors are highly effective in transducing most cells in different tissues, including acinar and ductal epithelial cells in salivary glands, 32 but they also evoke strong immune responses. 31, 33 Certainly, first-generation Ad5 vectors can provoke strong dose-dependent immune responses, including innate, cellular and humoral responses, after transduction of salivary gland cells. [34] [35] [36] [37] Interestingly, in rodents these specific immune responses cannot clear all transduced cells. 34 Indeed, Ad5 vector genomes can be found in rat submandibular glands 2, 6 and 12 months post transduction. 34, 36 Specifically, 24 h post transduction, one tenth of the delivered vector could be found in the transduced glands. Thirty days post transduction, Ad5 vector genome levels were reduced 100-fold further, but thereafter Ad5 genome levels remained stable until the termination time point of each experiment (2, 6 or 12 months). 34 In contrast, Ad5 vectors with the hCMVp usually elicited no measurable transgene expression after 14 days post transduction, even with its genome still present in the salivary glands. [34] [35] [36] [37] [38] Unfortunately, there are no in-vivo kinetic data examining Ad5 genome levels in human salivary glands post transduction with an Ad5 vector.
As we reported earlier, 1 there are reasonable explanations for why six of the subjects in the AdhAQP1 clinical trial were nonresponders. However, previously we had not addressed the question of why the time course for elevated salivary flow and peak response times in responders were so much later (7-42 days) than those seen when AdhAQP1 was tested pre-clinically in rats and miniature pigs (~3 days). 39, 40 As noted above, herein, we assessed the hypothesis that a reason for the longer times to peak expression seen in humans was possibly related to the methylation status of the hCMVp. Although the hCMVp has been shown to Immunofluorescence detection of hAQP1staining in submandibular glands (left), and hematoxylin and eosin staining (right) to show tissue morphology at different time points as indicated. All positive AQP1 staining in the control and day 14 groups in mice (d) and rats (h) were from blood vessels or red blood cells. (i) An enlarged representative image from a mouse sample 7 days post transduction, which clearly shows a positive AQP1 staining pattern in blood vessels and red blood cells (yellow arrows), and a positive AQP1 staining pattern in salivary epithelial cells (red arrows). There were four animals/group for these in-vivo experiments.
hCMVp is not methylated in human salivary gland cells be sensitive to methylation in many human cell lines in vitro and animal studies in vivo, [19] [20] [21] [22] [23] [24] [25] it was unclear whether the hCMVp was also sensitive to being methylated in human salivary gland cells, a preferential infection site for hCMV.
The data presented strongly suggest that the hCMVp in human salivary gland cells is not sensitive to methylation at both CpG and non-CpG sites, compared with results seen with rodent salivary gland cells. For example, as shown in Figure 3 and Table 1 , following AdhAQP1 transduction in vitro the hCMVp shows high levels of methylation in rodent cells, whereas none was observed in human cells. Furthermore, when assessed in vector-transduced mouse and rat salivary glands in vivo, similar very high levels of hCMVp methylation were seen in a time-dependent manner. Additional in-vitro studies with a rat salivary epithelial cell line, shown in Figure 4 , demonstrated that there was a loss of hAQP1 expression and function (that is, diminished cell volume responses) with time after AdhAQP1 transduction, which was similar to the increased methylation measured. Identical studies with a human salivary cell line showed no such change occurring in hAQP1 functional expression. Finally, when hAQP1 cDNA transcription was examined in mouse and rat submandibular glands over time after AdhAQP1 administration, it decreased faster than the loss of vector particles ( Figure 5 ). This suggests that in rodent glands, in vivo a mechanism other than vector clearance was responsible for the reduced detection of hAQP1, a conclusion consistent with the results found for hCMVp methylation (Figure 3 and Table 1 ).
In addition, we examined the possibility that previous exposure to hCMV may have had a role in the ability of subjects in the clinical trial to respond positively (that is, show increased salivary secretion and reduced xerostomic symptoms) following AdhAQP1 administration. We used the presence of IgG class antibodies to hCMV, to indicate a past history of exposure. However, there appears to be no relationship between responsiveness and past hCMV exposure, as of the five responders three were positive for past hCMV exposure, whereas two of the six nonresponders were positive. Although the number of subjects involved is small, the results suggest that past hCMV exposure probably does not have a role in their ability to respond to AdhAQP1 administration.
In summary, although all of the present findings are consistent with our hypothesis that the hCMVp in human salivary gland epithelial cells is much less sensitive to methylation than the hCMVp in rodent salivary gland epithelial cells, ultimately it will be necessary to perform direct studies with tissue obtained from in vivo-transduced human parotid glands, to provide a definitive explanation for the long-lived increased saliva secretion seen with the five responders in our recently reported AdhAQP1 clinical trial. 1 
MATERIALS AND METHODS
Recombinant viral vectors
Herein, we used the same vector, AdhAQP1, as used in our recent clinical trial (http://www.clinicaltrials.gov/ct/show/NCT00372320). 1 This vector is a first-generation, E1-deleted Ad5 vector that contains the hCMVp, hAQP1 cDNA and SV40 poly A in the deleted E1 region. Adcontrol was used as a control Ad5 vector. It contains no transgene and has been previously described. 34, 41 Cell culture A5 epithelial cells were derived from a rat submandibular gland and grown in McCoy's 5A medium (Invitrogen, Carlsbad, CA, USA). 42 SMIE epithelial cells were derived from a rat submandibular gland as well and were grown in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen). 43 NIH 3T3 cells were derived from mouse embryo fibroblasts and grown in DMEM. HSG epithelial cells were derived from an irradiated human submandibular gland and grown in DMEM/F12 medium. 44 HSY epithelial cells were derived from a human parotid adenocarcinoma and grown in DMEM/F12 medium. 45 One human primary cell culture studied was from the parotid gland of a normal volunteer. A second human primary cell culture studied was from a minor salivary gland of a normal volunteer. Gland tissue from volunteers was obtained under a clinical protocol approved by the National Institute of Dental and Craniofacial Research Institutional Review Board. Both primary cell cultures were grown in supplemented basal epithelial medium, DMEM/Ham's F12: 1/3 mixture (Invitrogen). 46 The following supplements were included in all cell cultures: 10% fetal bovine serum (Invitrogen), 100 U ml − 1 penicillin G and 100 μg ml − 1 streptomycin. Cells were incubated at 37°C in humidified 5% CO 2 .
In vitro transduction. Primary cell cultures from human salivary glands, HSG, HSY, A5, NIH 3T3 and SMIE cells were plated at 5 × 10 5 cells per well in six-well plates or glass-bottom culture dishes (35-mm petri dish, 14-mm microwell) and transduced with AdhAQP1 or Adcontrol at 100 particles per cell. Two or 7 days post transduction, the cells were used for measurement of cell volume or for extracting genomic DNA or protein, as appropriate.
Measurement of cell volume A5 and HSG cells were loaded with the fluoroprobe calcein (1 μM; 10 min; Molecular Probes, Inc., Eugene, OR, USA) and excited at 490 nm. Emitted fluorescence was measured at 510 nm as described by Liu et al. 47 Cells were exposed to hypotonic solution (from 300-150 mOsm by omitting NaCl from normal external solution). Change of fluorescence intensity was calculated as the percentage of volume change and peak time was defined as the time to reach maximum cell volume.
Experimental animals
Female C3H mice and male Wistar rats were 8 weeks old at the time of experimentation. All experiments were approved by the National Institute of Dental and Craniofacial Research Animal Care and Use Committee and were in compliance with the National Research Council's Guide for the Care and Use of Laboratory Animal Resources (1996) . Animals were anesthetized with ketamine (60 mg kg − 1 ) and xylazine (8 mg kg − 1 ) intramuscularly. Vectors were delivered to both submandibular glands by retrograde ductal instillation. 48 Groups of healthy mice or rats (n = 4 per time point for viral particle, protein and histological staining assays and n = 4 per time point for separate mRNA assay) received 10 9 particles per gland of AdhAQP1. Four nontransduced mice and rats were used as normal controls. Submandibular glands were collected from treated animals on days 2, 7 and 14 posttransduction for further analyses.
DNA methylation assay
Genomic DNA from cultured cells or submandibular glands was extracted with the QIAamp DNA Micro (Qiagen, Hilden, Germany). Three hundred nanograms of genomic DNA from each sample was processed using the MethylSEQr Bisulfite Conversion Kit (Applied Biosystems, Foster City, CA, USA), which converts nonmethylated cytosines to uracils. Methyl Primer Express Software (Applied Biosystems, Foster City, CA) was used for designing primers for PCR and sequencing. The primers, CMVF (5′-gggattt ttttatttggtagtatatt-3′) and CMVR (5′-aactctacttatataaacctcccac-3′), were used for amplifying a 256-bp PCR amplicon from the 773-bp hCMVp for sequencing.
Enzyme-linked immunosorbent assay
A CMV IgG enzyme-linked immunosorbent assay kit (Diagnostic Automation/Cortez Diagnostics, Inc., Calabasas, CA, USA) was used hCMVp is not methylated in human salivary gland cells C Zheng et al to determine the presence of antibodies to human CMV in serum obtained from all 11 subjects in the clinical trial (NCT00372320).
Immunofluorescence staining Submandibular glands from mice and rats were fixed in 10% formalin and embedded in paraffin. Sections (5 um) were deparaffinized and rehydrated in a graded series of ethanol, then washed in phosphate buffered saline. Antigen retrieval was carried out with 1 mmol l − 1 EDTA (pH 8) and 0.05% Tween 20 in a microwave oven for 10 min. Sections were then blocked with 20% goat serum in 5% bovine serum albumin for 1 h, incubated with primary antibodies, either rabbit monoclonal anti-aquaporin-1 or normal rabbit IgG as an antibody control (Abcam, Inc., Cambridge, MA, USA), in 5% bovine serum albumin in phosphate buffered saline for 1 h at room temperature and washed with phosphate buffered saline. Next, the slides were incubated with secondary antibody-Alexa Fluor 488 donkey anti rabbit IgG (H+L) (Invitrogen) for 1 h, washed with phosphate buffered saline and mounted with Prolong Gold antifade reagent with DAPI (4′, 6-diamidino-2phenylindole; Invitrogen).
PCR assays
Two conventional PCR assays were used to evaluate the presence of the hCMVp in all cells and cell lines before use in this study. For each, 500 ng of genomic DNA, obtained as above, was used per PCR reaction. PCR 1 amplicon (256 bp) was amplified by hCMVF1 (5′-gggactttcctacttggcagtacatc-3′) and hCMVR1 (5′-agctctgcttat atagacctcccac-3′). PCR 2 amplicon (506 bp) was amplified by hCMVF2 (5′-cgcgttacataacttacggta-3′) and hCMVR2 (5′-tctgct tatatagacctcccaccg-3′).
Quantitative PCR assays A DNA sample from 20 μg salivary gland tissue was used for each quantitative PCR reaction. The primers CMV-AQP1q1 (5′-cgtgta cggtgggaggtctatataa-3′) and CMV-AQP1q2 (5′-gctggtaccgagct cgaatt-3′), and probe CMV-AQP1probe1 (5′-/56-FAM/aaccgtcaga tccggtcgcgc/36-TAMTSp/-3′), specific for AdhAQP1, were used to measure vector copy number in submandibular glands. An mRNA sample from 20 μg gland tissue was extracted using RNeasyMicroarray Tissue Mini Kit (Qiagen) and used for the reverse transcriptase-quantitative PCR reaction (Qiagen). The primers AQP1q3 (5′-tggctgtgggattaaccctg-3′) and AQP1q4 (5′-tggt tgctgaagttgtgtgtga-3′), and probe AQP1probe2 (5′-/56-FAM/ cggtcctttggctccgcggt/36-TAMTSp/-3′), specific for the hAQP1 mRNA, were used to quantify hAQP1 mRNA in submandibular glands. All quantitative PCR assays were done in an ABI Prism 7700 Sequence Detector (PE Applied Biosystems, Foster City, CA, USA) as follows: 95°C for 2 min, 95°C for 8 min, 95°C for 15 s and 60°C for 1 min for 40 cycles.
Western blot analysis Samples from rodent submandibular glands were homogenized in 400 μl of CelLyticTMM Cell Lysis Reagent (Sigma, St Louis, MO, USA). HSG cells and A5 cells from (5 × 10 6 cells) were lysed with 500 μl of the same reagent. Thereafter, 30 μg of protein, obtained from cell supernatants, were mixed with NuPAGE LDS Sample Buffer (4 × ; Invitrogen) and loaded onto SDS-PAGE gels for western blottings using rabbit polyclonal anti-rat AQP1 antibody (Alpha Diagnostic Intl, Inc., San Antonio, TX, USA) and mouse monoclonal anti-β-actin antibody (Abcam, Inc.) for detection. Densitometric measurements were performed using ImageJ software (National Institutes of Health, Bethesda, MD, USA). The hAQP1 protein band was normalized to β-actin, which was used as an internal control.
Statistical analysis
Data analyses were conducted using Origin 9 (OriginLab, Northampton, MA, USA). Results herein are presented as mean values ± s.e.m. Differences with a Po0.05 were considered significant.
